Electronic Spirometer

Electronic Spirometer

The electronic spirometer market is expected to register a CAGR of approx. 5% over the period of 2023-2030. The electronic spirometer market refers to the industry that focuses on the manufacturing, distribution, and sales of electronic spirometers. A spirometer is a medical device used to measure lung function and diagnose respiratory conditions such as asthma, chronic obstructive pulmonary disease (COPD), and other pulmonary disorders. Electronic spirometers are advanced versions of spirometry devices that incorporate electronic components, sensors, and software to provide accurate and precise measurements of lung capacity and airflow. These devices typically feature digital displays, data storage capabilities, and connectivity options for data transfer and analysis. The growing demand for electronic spirometers can be attributed to the increasing prevalence of respiratory diseases around the globe. For instance, according to the national center for health statistics, the prevalence of physician ambulatory-care visits for respiratory diseases is highest in persons aged >85 years and is 57% and 85% lower in those aged 75 to 84 years and 65 to 74 years, respectively. Respiratory-disease mortality rates across these age groups were within 15% of each other. Owing to the glaring statistics the increasing prevalence rate is growing in the case of respiratory diseases which increases the demand for spirometers for checking lung capacity and would contribute to the growth of the market in the forthcoming period as well. Moreover, the growing awareness about the importance of early diagnosis and timely intervention in respiratory diseases. Electronic spirometers enable healthcare professionals to detect lung function abnormalities and respiratory disorders at an early stage, facilitating early treatment and better patient outcomes. Furthermore, the electronic spirometer market is anticipated to grow on account of the rise in research and development activities. However, some of the restraints in the market, including the high production costs and lack of skilled professional loading are impeding the growth of this market all over the world.

• Based on type, the market is segmented into hand-held spirometers and table-top spirometers. Among them, the table-top spirometers segment captured a significant share of the market in 2022. A tabletop spirometer is an improved version of a traditional spirometer that helps measure lung function. It can be easily moved from one place to another, making it more convenient and easier to use. The portable model is compact and made from robust materials, so it can be easily handled during testing procedures without compromising the quality or accuracy of the results.
• Based on the application, the electronic spirometer market has been classified into asthma, COPD, chronic bronchitis, and others. Among them, the COPD category grabbed a considerable market share and is expected to grow at a significant CAGR during the forecast period. This is due to the high number of people suffering worldwide from mild to severe COPD and the easy diagnosis of COPD through spirometry. In Europe, the prevalence of COPD was estimated to be around 7.6%. Spirometry plays an extremely important role in the diagnosis and monitoring of COPD.
• Based on the end-user, the electronic spirometer market has been classified into hospital, clinical laboratory, and homecare. Among them, the hospital category grabbed a considerable market share and is expected to grow at a significant CAGR during the forecast period. Spirometry is extensively performed in hospitals and clinics to diagnose and monitor chronic respiratory disorders. The rapidly growing ageing population, the increase in reimbursements for clinical tests performed in hospitals, and the launch of advanced devices are the factors driving the growth of the segment.
• For a better understanding of the market adoption of electronic spirometers, the market is analyzed based on its worldwide presence in the countries such as North America (U.S., Canada, and Rest of North America), Europe (Germany, France, Italy, Spain, U.K., and Rest of Europe), Asia-Pacific (China, Japan, India, and Rest of APAC), and Rest of World. Electronic spirometers have gained increasing popularity in North America due to various factors. The North America region has witnessed a significant rise in the prevalence of respiratory diseases such as asthma, COPD, and lung cancer. This increasing burden of respiratory conditions has created a higher demand for electronic spirometers for accurate diagnosis, monitoring, and management of these diseases. In addition, Advancements in technology have led to the development of more advanced electronic spirometers with improved accuracy, ease of use, and connectivity features. These devices offer enhanced data analysis capabilities, intuitive user interfaces, and seamless integration with electronic health records (EHR) systems. Such technological advancements have contributed to the growth of the electronic spirometer market in North America. Moreover, several companies in the electronic spirometer market have engaged in strategic collaborations and partnerships to expand their market presence and enhance their product offerings. These collaborations often focus on integrating spirometry solutions with other healthcare technologies, such as electronic health records, telemedicine platforms, and respiratory management software. Such collaborations have boosted market growth by providing comprehensive respiratory care solutions. For instance, In March 2021, Philips Healthcare, a leading player in the electronic spirometer market, launched the Philips Respironics E30 ventilator to address the increased demand for respiratory care during the COVID-19 pandemic. The device offers a simplified setup, easy operation, and remote monitoring capabilities, making it suitable for both home and healthcare facility use.
• Some of the major players operating in Hill-Rom Holdings, Inc, GANSHORN Medizin Electronic GmbH, CareFusion Corporation, COSMED srl, Philips Healthcare, Fukuda Sangyo Co., Ltd, MGC Diagnostics Corporation, Sibelmed, SDI Diagnostics, Medical International Research among others. Several M&A’s along with partnerships have been undertaken.